Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Библиографические подробности
Главные авторы:	Stylianou, E, Betts, G, Dicks, M, Griffiths, K, Poyntz, H, Mcshane, H
Формат:	Conference item
Опубликовано:	2011

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
по: Betts, G, и др.
Опубликовано: (2012)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
по: Griffiths, K, и др.
Опубликовано: (2013)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
по: Gareth Betts, и др.
Опубликовано: (2012-01-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
по: Griffiths, K, и др.
Опубликовано: (2011)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
по: Stylianou, E, и др.
Опубликовано: (2015)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
по: Poyntz, H, и др.
Опубликовано: (2011)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
по: Poyntz, H, и др.
Опубликовано: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
по: Marsay, L, и др.
Опубликовано: (2013)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
по: Poyntz, H, и др.
Опубликовано: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
по: Marsay, L, и др.
Опубликовано: (2013)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
по: Christopher J. De Voss, и др.
Опубликовано: (2025-02-01)

Viral vector delivery of Env trimer immunogens
по: Parks CL, и др.
Опубликовано: (2012-09-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
по: Dicks, M, и др.
Опубликовано: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
по: Meyer, J, и др.
Опубликовано: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
по: Meyer, J, и др.
Опубликовано: (2013)

Viral vectors as vaccine platforms: from immunogenicity to impact
по: Ewer (nee Russell), K, и др.
Опубликовано: (2016)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
по: Biswas, S, и др.
Опубликовано: (2011)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
по: Poyntz, HC
Опубликовано: (2012)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
по: Mcshane, H, и др.
Опубликовано: (2001)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
по: Rowland, R, и др.
Опубликовано: (2013)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
по: Sumi Biswas, и др.
Опубликовано: (2011-01-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
по: Dicks, M, и др.
Опубликовано: (2011)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
по: Sushmita Kumari, и др.
Опубликовано: (2022-08-01)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
по: Dean, G, и др.
Опубликовано: (2014)

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus
по: López-Camacho, C, и др.
Опубликовано: (2019)

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
по: Aiquan Chang, и др.
Опубликовано: (2022-02-01)

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
по: César López-Camacho, и др.
Опубликовано: (2019-04-01)

Protection by Persuasion: International Cooperation in the Refugee Regime
по: Betts, A
Опубликовано: (2010)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
по: Dean, G, и др.
Опубликовано: (2014)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
по: Dicks, M, и др.
Опубликовано: (2012)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
по: Sander, C, и др.
Опубликовано: (2009)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
по: Vordermeier, H, и др.
Опубликовано: (2009)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
по: White, A, и др.
Опубликовано: (2013)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
по: Vordermeier, H, и др.
Опубликовано: (2011)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
по: Goonetilleke, N, и др.
Опубликовано: (2003)

Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles
по: Tingfeng Wang, и др.
Опубликовано: (2024-12-01)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
по: Stylianou, E, и др.
Опубликовано: (2019)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
по: Dulce Mata-Espinosa, и др.
Опубликовано: (2023-10-01)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
по: Brookes, R, и др.
Опубликовано: (2008)

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats
по: Aigerim Mailybayeva, и др.
Опубликовано: (2020-02-01)

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Схожие документы

Схожие документы